The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications

Erwan Guyot,Aline Chevallier,Robert Barouki,Xavier Coumoul
DOI: https://doi.org/10.1016/j.drudis.2012.11.014
IF: 8.369
2013-05-01
Drug Discovery Today
Abstract:The aryl hydrocarbon receptor (AhR) is a transcription factor which is activated by diverse compounds and regulates the expression of xenobiotic metabolism genes. Recent studies have unraveled unsuspected physiological roles and novel alternative ligand-specific pathways for this receptor. In this review, we discuss these novel aspects and focus on the different responses elicited by the diverse endogenous and/or exogenous AhR ligands. In addition to challenging the relevance of the 'agonist/antagonist' classification of ligands, we introduce the concept of AhR plasticity as a primordial factor in the generation of these pathways. Finally, we suggest several promising perspectives for the pharmacological modulation of these responses.
pharmacology & pharmacy
What problem does this paper attempt to address?